Holen Sie sich die Stockscreener-App
3.53
1.67%
-0.06
Handel nachbörslich:
3.54
0.01
+0.28%
Schlusskurs vom Vortag:
$3.59
Offen:
$3.65
24-Stunden-Volumen:
37,419
Relative Volume:
0.47
Marktkapitalisierung:
$54.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.31M
KGV:
-4.5844
EPS:
-0.77
Netto-Cashflow:
$-12.65M
1W Leistung:
+1.44%
1M Leistung:
-1.94%
6M Leistung:
+10.14%
1J Leistung:
+1.58%
1-Tages-Spanne:
$3.48
$3.65
1-Wochen-Bereich:
$3.48
$3.75
52-Wochen-Spanne:
$1.75
$3.938
Grace Therapeutics Inc Stock (GRCE) Company Profile
Firmenname
Grace Therapeutics Inc
Sektor
Branche
Telefon
609-322-1602
Adresse
103 CARNEGIE CENTER, PRINCETON
Compare GRCE vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.53 | 55.55M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2020-09-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-18 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Grace Therapeutics Inc Aktie (GRCE) Neueste Nachrichten
Grace Therapeutics announces third quarter 2026 financial results, provides business update - marketscreener.com
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results - MarketBeat
Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus
Grace: Fiscal Q3 Earnings Snapshot - kare11.com
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q3 2026 Financial Results and Business Update - TradingView
April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Moderna | History, Innovation, Challenges, & Facts - Britannica
Aug Selloffs: What are the risks of holding BioXcel Therapeutics Inc.Weekly Volume Report & Consistent Growth Stock Picks - mfd.ru
Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Volatility Watch: Can SolarBank Corporation generate free cash flowJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Aug Fed Impact: Why is Grace Therapeutics Inc stock going upMarket Trend Review & Smart Allocation Stock Tips - baoquankhu1.vn
Big Money Moves: Can Tower Semiconductor Ltd weather a recessionQuarterly Trade Report & AI Powered Market Entry Ideas - baoquankhu1.vn
Quarterly Recap: Does IMMR stock benefit from AI growthMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
Gainers Report: Can Grace Therapeutics Inc weather a recessionTake Profit & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Up 34.6% in January - MarketBeat
Dividend Watch: Is ETRACS 2xMonthly Pay Leveraged Index ETN benefiting from interest rate changesMarket Risk Report & Capital Protection Trade Alerts - baoquankhu1.vn
New Highs: Is Grupo Supervielle SA Depositary Receipt a strong candidate for buy and holdJuly 2025 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
What is Chicago Atlantic Real Estate Finance Inc. s 5 year growth outlookJuly 2025 Selloffs & Stepwise Trade Execution Plans - mfd.ru
P 500July 2025 Patterns & Stepwise Entry and Exit Trade Signals - mfd.ru
Chart Watch: Will XPON outperform small cap indexesIndex Update & Weekly Breakout Watchlists - baoquankhu1.vn
Why APYX stock attracts strong analyst attention - baoquankhu1.vn
Trading Recap: Will Bullfrog AI Holdings Inc Equity Warrant stock recover after earningsQuarterly Profit Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Update Recap: Why is Grace Therapeutics Inc stock going up2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn
Bull Bear: Does Grace Therapeutics Inc have a sustainable dividendJuly 2025 PreEarnings & High Return Stock Watch Alerts - baoquankhu1.vn
Grace Therapeutics (NASDAQ:GRCE) vs. Adhera Therapeutics (OTCMKTS:ATRX) Financial Review - Defense World
WESCO International, Inc. (NYSE:WCC) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Grace Therapeutics (NASDAQ:GRCE) Stock Rating Upgraded by Wall Street Zen - Defense World
Published on: 2026-01-25 20:15:18 - baoquankhu1.vn
AIGH Capital Management LLC Sells 221,280 Shares of Grace Therapeutics, Inc. $GRCE - Defense World
Ovintiv Inc. (TSE:OVV) Receives Average Rating of “Buy” from Analysts - Defense World
Big Picture: Is Amcor plc a strong growth stockPortfolio Update Report & Expert Verified Movement Alerts - baoquankhu1.vn
Ten new option listings and two option delistings on January 22nd - TipRanks
What’s Grace Therapeutics Inc.’s historical returnAnalyst Upgrades & Free Superior Profit Margins - Bollywood Helpline
Why Grace Therapeutics Inc. stock remains a top recommendationSupport Level Holds & Superior Capital Trading - Bollywood Helpline
Is Grace Therapeutics Inc benefiting from interest rate changes2025 Volatility Report & Daily Stock Trend Reports - baoquankhu1.vn
Grace Therapeutics, Inc. (NASDAQ:GRCE) Sees Significant Increase in Short Interest - MarketBeat
Earnings Risk: Should you avoid XPeng Inc Depositary Receipt stock right nowTrade Exit Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Stock Report: What are the future prospects of BMBLTrade Risk Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
Aug Technicals: Can Grace Therapeutics Inc maintain sales growth2025 Analyst Calls & Short-Term High Return Ideas - baoquankhu1.vn
• Diversification across cement stocks recommendedMarket Liquidity Analysis & Big Gains Low Cost - bollywoodhelpline.com
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - The Malaysian Reserve
Can Grace Therapeutics Inc. weather a recessionRate Cut & Safe Capital Growth Trade Ideas - bollywoodhelpline.com
Market Review: Why is Grace Therapeutics Inc stock going up2025 Year in Review & Verified Technical Signals - baoquankhu1.vn
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms - The Globe and Mail
Rally Mode: Is MOG.B a defensive stock2025 Volume Leaders & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Grace Therapeutics updates executive severance terms following contract amendments By Investing.com - Investing.com Australia
Grace Therapeutics updates executive severance terms following contract amendments - Investing.com
Grace Therapeutics secures up to $30 million financing - MSN
Grace Therapeutics reports positive Phase 3 trial results for GTx-104 - MSN
Finanzdaten der Grace Therapeutics Inc-Aktie (GRCE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):